$LDOS

May Gary Stephen sold $141K of LDOS

May Gary Stephen sold 1,000 shares of Leidos Holdings, Inc. (LDOS) at $140.85 ($0.14M total) on 2026-09-01.

Original reporting
SEC EDGAR · May Gary Stephen
Published Sep 2, 2026, 8:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 9:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LDOS
Neutral
high confidence
Mentioned
$LDOS
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LDOSNeutralLow
01

Why it matters

The disclosed sale is modest and does not alter the company's fundamentals or outlook.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential tax planning or portfolio rebalancing motives are not disclosed.

Relevance 4/10Novelty 3/10Timing: filing date 2026-09-02

Background

Leidos is a defense and IT services contractor; insider transactions are routinely monitored by investors.

Company-level read

Ticker impact

$LDOSNeutralHigh confidence
Context

Director May Gary Stephen sold 1,000 shares of Leidos for $140,845, reducing his stake to 10,204 shares.

Expected impact

No significant price change expected.

Evidence & confidence

The sale size is small relative to total float and typical insider transactions, so market impact is minimal.

Market effects

No broader sector impact; insider sale is company‑specific.

Limited to US equities market; no regional effect.

Negligible on a global scale.

Counterpoint

If the insider is reallocating capital, it could signal confidence in other opportunities, but unlikely to affect LDOS.

Key entities

  • Leidos Holdings, Inc.

    US defense and technology services provider.

  • May Gary Stephen

    Board member of Leidos who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LDOSMedAI 9/10

Infrastructure Acquisition. Is This a Quiet AI Winner?

Leidos (NYSE: LDOS) reported Q3 revenue of $4.6B (+7% YoY) and raised 2026 guidance to $18.2B-$18.4B revenue, $12.20-$12.50 EPS. It acquired ENTRUST for $2.4B, expanding energy infrastructure. Near-term margins may dip due to acquisition costs, but long-term growth is expected from AI data center energy demand.

$AZNHighAI 8/10

AstraZeneca, Leidos, Expeditors International: CNBC ‘Final Trades’ - Expeditors International (NYSE:EXPD)

CNBC's 'Final Trades' featured picks from Jim Lebenthal (AstraZeneca, AZN), Stephen Weiss (Leidos, LDOS), Liz Thomas (Treasuries), and Joseph Terranova (Expeditors, EXPD). AZN reported regulatory approvals and strong trial data, LDOS beat Q2 estimates and raised guidance, and EXPD also exceeded Q2 expectations. Shares of AZN, LDOS, and EXPD rose 2.3%, 3.1%, and 0.5% respectively on Monday.

$LDOSMedAI 9/10

LDOS Looks 22.8% Undervalued on GF Value™

Leidos Holdings Inc (LDOS) secured an $875M contract extension from the U.S. Navy. The stock is trading at $132.83, 22.8% below its GF Value™ of $171.99, indicating undervaluation. LDOS has a GF Score™ of 78/100, reflecting strong financial health and profitability. Insiders sold $3.2M in shares over the past year.